Iambic Therapeutics IAM Growth Metrics (2025)

NASDAQ IAM
$14.78 +1.52 (+11.46%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Iambic Therapeutics Quarterly Growth Metrics

Periods 1 quarter
Latest Dec 2025

Iambic Therapeutics reported asset growth of 25.21% for the quarter ended Dec 2025. These growth metrics cover 1 quarter of results, standardized by Business Quant from the company’s SEC filings.

Iambic Therapeutics Growth Metrics API

Pull Iambic Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IAM&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY